23
War & Conflict5h 2m ago

Gland Pharma Limited’s Board approved the re-appointment of Mr. Udo Johannes Vetter and the appointment of Mr. William Robert Keller as Independent Directors, effective June 15, 2026, following the resignation of Mr. Satyanarayana Murthy Chavali due to a potential conflict of interest.

Archive Window: 7 Days Left

not specified

Who
Mr. Udo Johannes Vetter, Mr. William Robert Keller, Mr. Satyanarayana Murthy Chavali, Mr. Essaji Goolam Vahanvati, Gland Pharma Limited’s Board, Sampath Kumar Pallerlamudi
What
Gland Pharma Limited’s Board approved the re-appointment of Mr. Udo Johannes Vetter and the appointment of Mr. William Robert Keller as Independent Directors, effective June 15, 2026, following the resignation of Mr. Satyanarayana Murthy Chavali due to a potential conflict of interest.
When
Mon, 15 Jun 2026 21:48:44 GMT · 5h 2m ago
Where
not specified ·
Why
Mr. Satyanarayana Murthy Chavali resigned as an Independent Director due to a potential conflict of interest arising from a company where he is a Promoter and Director proposing to enter a business segment overlapping with Gland Pharma’s future activities.
The Frontline Impact

How this affects you

This board restructuring ensures Gland Pharma's compliance with regulatory requirements and addresses potential conflicts of interest, reflecting a proactive approach to corporate governance.

Story chain

3 events in this thread
  1. Currently Reading5h 2m ago
    Gland Pharma Limited’s Board approved the re-appointment of Mr. Udo Johannes Vetter and the appointment of Mr. William Robert Keller as Independent Directors, effective June 15, 2026, following the resignation of Mr. Satyanarayana Murthy Chavali due to a potential conflict of interest.
  2. War & Conflict5h 2m ago
    Gland Pharma Limited’s Board approved the re-appointment of Mr. Udo Johannes Vetter for a second term and the appointment of Mr. William Robert Keller as an Independent Director, effective June 15, 2026.
    Open article
  3. War & Conflict5h 2m ago
    Gland Pharma Limited’s Board approved the re-appointment of Mr. Udo Johannes Vetter and the appointment of Mr. William Robert Keller as Independent Directors, effective June 15, 2026, following the resignation of Mr. Satyanarayana Murthy Chavali.
    Open article

Verified Sources & Citations